Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 19 years of age or older
- You must be taking the medication mavacamten as directed by its approved prescribing guidelines
- You must be willing and able to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You may not be eligible if you have been prescribed mavacamten for a reason that has not been officially approved in Korea
- You may not be eligible if mavacamten is considered medically unsuitable or unsafe for you based on the official Korean prescribing guidelines approved by the Ministry of Food and Drug Safety (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.